Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0984720070390040202
Infection and Chemotherapy
2007 Volume.39 No. 4 p.202 ~ p.207
In-Vitro Activity of Tosufloxacin Compared with Levofloxacin and Ofloxacin against Uropathogens, Isolated from Acute Uncomplicated Cystitis in Female Outpatients
Lee Seung-Ju

Lee Kyu-Sung
Jeong Seong-Jin
Lee Sang-Eun
Cho Yong-Hyun
Abstract
Background : Tosufloxacin is one of the fluoroquinolones with higher antibacterial activity against many organisms than other fluoroquinolones developed previously. However, the antimicrobial susceptibilities of tosufloxacin against uropathogens are not well known. The objective of this study was to compare minimum inhibitory concentrations (MICs) of tosufloxacin with those of levofloxacin and ofloxacin for uropathogens cultured from the urine of female outpatients with acute uncomplicated cystitis.

Materials & Methods : We collected and cultured urine samples from four metropolitan hospitals between August 2006 and November 2006. The MICs of tosufloxacin, levofloxacin and ofloxacin were determined for 89 isolates using an agar dilution method.

Results : The most prevalent causative organism was Escherichia coli (70.8%). The MIC distribution of tosufloxacin and levofloxacin showed a bimodal distribution for E. coli. The two modes for E. coli were 0.03 and 32 ¥ìg/mL for tosufloxacin and 0.03 and 16 ¥ìg/mL for levofloxacin. However, ofloxacin had one more peak at MIC 0.5 ¥ìg/mL. MIC50s of tosufloxacin, levofloxacin and ofloxacin for E. coli were 0.03 ¥ìg/mL, 0.06 ¥ìg/mL and 0.125 ¥ìg/mL, respectively. Tosufloxacin, the newer fluoroquinolone, was more active than levofloxacin and ofloxacin against both E. coli and Gram-positive bacteria.

Conclusion : Of the studied fluoroquinolones tosufloxacin had the lowest MICs against uropathogens and could be considered a promising alternative fluoroquinolone agent for the treatment of urinary tract infection.
KEYWORD
Cystitis, Susceptibility, Fluoroquinolones
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø